Circulating Rare Cells Enable Highly Efficient Cancer Detection - Medical University of Vienna

Researchers from the Medical University of Vienna presented a scientific poster at the American Association of Cancer Research 2015 meeting, detailing a protocol combining the novel microfluidic Parsortix technology with qPCR, to enable the molecular analysis of circulating tumor cells (CTCs) implicated in ovarian and breast cancer. The Parsortix™ system was utilised for capturing and analyzing mRNA of circulating tumor cells. The new technique will allow the implementation of ‘liquid biopsies’ in cancer detection studies and as a companion diagnostic in clinical trials.